These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4006105)

  • 21. Differential reactivity to 5-hydroxytryptamine in canine coronary arteries.
    Gutterman DD; Rusch NJ; Hermsmeyer K; Dole WP
    Blood Vessels; 1986; 23(4-5):165-72. PubMed ID: 3779106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cells and the electrical and mechanical responses of the rabbit coronary artery to 5-hydroxytryptamine.
    Garland CJ
    J Pharmacol Exp Ther; 1985 Apr; 233(1):158-62. PubMed ID: 3981453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs.
    Woodman OL
    Br J Pharmacol; 1990 May; 100(1):153-7. PubMed ID: 2372656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of angiotensin II on canine and porcine coronary epicardial and resistance arteries.
    Myers PR; Katwa LC; Tanner M; Morrow C; Guarda E; Parker JL
    J Vasc Res; 1994; 31(6):338-46. PubMed ID: 7986958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constriction of a large coronary artery contributes to serotonin-induced myocardial ischemia in the dog with pliable coronary stenosis.
    Ichikawa Y; Yokoyama M; Akita H; Fukuzaki H
    J Am Coll Cardiol; 1989 Aug; 14(2):449-59; discussion 460-1. PubMed ID: 2754130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs.
    Brum JM; Sufan Q; Lane G; Bove AA
    Circulation; 1984 Dec; 70(6):1066-73. PubMed ID: 6499144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte and platelet-derived factors augment canine coronary constriction to serotonin.
    Cappelli-Bigazzi M; Lamping KG; Nuno DW; Harrison DG
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1161-70. PubMed ID: 2171364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of endothelial function in coronary resistance vessels by saponin.
    Wiest E; Trach V; Dämmgen J
    Basic Res Cardiol; 1989; 84(5):469-78. PubMed ID: 2818447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis.
    Kawachi Y; Tomoike H; Maruoka Y; Kikuchi Y; Araki H; Ishii Y; Tanaka K; Nakamura M
    Circulation; 1984 Feb; 69(2):441-50. PubMed ID: 6690109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiographic demonstration of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium.
    Shimokawa H; Vanhoutte PM
    J Am Coll Cardiol; 1991 Apr; 17(5):1197-202. PubMed ID: 2007721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
    Khalil A; Carrier M; Latour JG; Pelletier LC
    Circulation; 1996 Nov; 94(9 Suppl):II308-11. PubMed ID: 8901766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs.
    Rosendorff C; Hoffman JI; Verrier ED; Rouleau J; Boerboom LE
    Circ Res; 1981 Mar; 48(3):320-9. PubMed ID: 6109581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of atherosclerosis on the coronary microcirculation.
    Chilian WM; Dellsperger KC; Layne SM; Eastham CL; Armstrong MA; Marcus ML; Heistad DD
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H529-39. PubMed ID: 2309917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of endothelin on the coronary vascular bed in open-chest dogs.
    Clozel JP; Clozel M
    Circ Res; 1989 Nov; 65(5):1193-200. PubMed ID: 2680149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of human coronary arteries to serotonin after injury by coronary angioplasty.
    Mc Fadden EP; Bauters C; Lablanche JM; Quandalle P; Leroy F; Bertrand ME
    Circulation; 1993 Nov; 88(5 Pt 1):2076-85. PubMed ID: 8222101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine.
    Drexler H; Zeiher AM; Meinzer K; Just H
    Lancet; 1991 Dec 21-28; 338(8782-8783):1546-50. PubMed ID: 1683971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated perfused rabbit coronary artery and aortic strip preparations: the role of endothelium-derived relaxant factor.
    Griffith TM; Henderson AH; Edwards DH; Lewis MJ
    J Physiol; 1984 Jun; 351():13-24. PubMed ID: 6611406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition.
    Holtz J; Förstermann U; Pohl U; Giesler M; Bassenge E
    J Cardiovasc Pharmacol; 1984; 6(6):1161-9. PubMed ID: 6084775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasomotor activity of moderately well-developed canine coronary collateral circulation.
    Hautamaa PV; Dai XZ; Homans DC; Bache RJ
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H890-7. PubMed ID: 2466413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.